Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA clears Novo Nordisk's diabetes drug to reduce cardiovascular risk
FDA clears Novo Nordisk's diabetes drug to reduce cardiovascular risk
FDA clears Novo Nordisk's diabetes drug to reduce cardiovascular risk
Submitted by
admin
on August 26, 2017 - 11:56am
Source:
Yahoo/Reuters
News Tags:
Novo Nordisk
FDA
diabetes
Victoza
Headline:
FDA clears Novo Nordisk's diabetes drug to reduce cardiovascular risk
Do Not Allow Advertisers to Use My Personal information
